Gene removal in immune cells eased MS-like disease in mice
By MS Buddy ·
Summarized from Science immunology, Jun 2025 · PubMed · DOI. AI-generated summary. Not medical advice.
Animal study · mice with an MS-like disease or inflammatory bowel disease
Research by Liwei Wang, Stefan Feske and 12 colleagues at New York University Grossman School of Medicine in the United States.
Does removing a gene from immune cells ease MS-like disease in mice?
Key Takeaway
Removing a gene from immune cells protected mice from an MS-like disease and inflammatory bowel disease.

What They Found
Researchers found that a gene in immune cells helped drive inflammation in mice with an MS-like disease. Removing the gene from those cells protected mice from the MS-like disease and inflammatory bowel disease. Without the gene, the immune cells had more DNA damage. The cells also stopped dividing, grew in number less, and were less able to carry out their usual roles. The researchers found that the gene helped control processes that repair DNA and allow cells to divide.
Who Should Care and Why
This study used mice with an MS-like disease, not people with MS. It also studied mice with inflammatory bowel disease. The researchers focused on immune cells that can drive inflammation. Removing a gene from these cells changed how they grew and worked. The findings help explain how those immune cells may contribute to disease in mice.
Important Considerations
You cannot tell from this mouse study whether the same gene has the same role in people with MS. You cannot tell whether changing this gene would treat MS in people. The abstract does not state how many mice were studied.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Science immunology by et al.. Reproduced from the PubMed record.
Pathogenic CD4 T cells drive autoimmunity in diseases such as multiple sclerosis (MS) and inflammatory bowel disease (IBD). Through a forward genetic screen, we identified chloride nucleotide-sensitive channel 1A (CLNS1A) as a key regulator of inflammation in the experimental autoimmune encephalomyelitis (EAE) model of MS. CLNS1A is expressed in several subsets of CD4 T cells, including pathogenic T helper 17 (pTH17) cells. Deletion of Clns1a in T cells resulted in DNA damage, cell cycle arrest, impaired T cell proliferation, and effector function, thereby protecting mice from both EAE and IBD. We found that CLNS1A interacts with protein arginine methyl transferase 5 (PRMT5). Moreover, CLNS1A regulates symmetric histone dimethylation and the expression of genes involved in DNA repair, replication, and cell cycle progression. Thus, CLNS1A plays an important role in CD4 T cells by promoting genome stability and cell cycle progression.
Categories
Explore more research
Related MS research

11/15/2026
In tissue from mice with an MS-like disease, a lab drug reduced excess chemical release from nerve e
Read More
11/13/2026
A review compares MS with harmful drug reactions and proposes ways to test how immune genes, lasting
Read More
11/13/2026
This review examines how vitamin D and vitamin A signals shape immune activity in MS and other disea
Read More
11/12/2026
In mice with an MS-like disease, a lab-made protein improved movement and thinking. Researchers also
Read More
11/12/2026
A review proposes how the Epstein-Barr virus might contribute to MS. The model brings earlier ideas
Read More
11/11/2026
This review compares inherited and environmental risks for MS starting in childhood or adulthood, in
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
